Tudor Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$952K Buy
1,035
+5
+0.5% +$5.07K 0.49% 65
2025
Q4
$1.11M Sell
1,030
-54
-5% -$51.6K 0.57% 51
2025
Q3
$827K Buy
1,084
+5
+0.5% +$3.72K 0.44% 64
2025
Q2
$841K Sell
1,079
-8
-0.7% -$6.22K 0.48% 59
2025
Q1
$898K Buy
1,087
+1
+0.1% +$832 0.54% 54
2024
Q4
$839K Buy
1,086
+634
+140% +$525K 0.49% 61
2024
Q3
$400K Buy
+452
New +$406K 0.25% 98

Other funds holding LLY

Tudor Financial's LLY Position: Q1 2026 in Review

Tudor Financial increased its Eli Lilly (LLY) stake by 0.49% in Q1 2026, buying an estimated $5.07K and bringing the position to 1,035 shares worth $952K. The position accounts for 0.49% of the portfolio, ranked #65.

Tudor Financial first reported a position in LLY in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.11M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Tudor Financial held 1,035 shares of Eli Lilly worth $952K as of Q1 2026.
  • Tudor Financial bought 5 Eli Lilly shares in Q1 2026, an estimated $5.07K.
  • Eli Lilly made up 0.49% of Tudor Financial's portfolio in Q1 2026, its #65 holding.
  • Tudor Financial first reported a position in Eli Lilly in Q3 2024 and has held it in 7 quarters since.
  • Tudor Financial's Eli Lilly position peaked at $1.11M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Tudor Financial's 13F filing for Q1 2026, filed 14 May 2026.